SCHEMBL19494270

SCHEMBL19494270

NC(=O)c1cc(SN2CCCCC2)sc1NC(=O)c1ccccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.48
▸ CFTR P13569 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ MAPT P10636 5/20 0.46
▸ LMNA P02545 3/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ TP53 P04637 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ TNF P01375 1/20 0.42
▸ NOD1 Q9Y239 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ CNR1 P21554 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494889 0.87 NPC1 (0.48) RAB9ANPC1MAPTLMNAL3MBTL1
SCHEMBL19494688 0.85 MAPT (0.52) RAB9ANPC1MAPTSMN1; SMN2MEN1
SCHEMBL19494409 0.79 IRAK4 (0.48) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL19494581 0.79 CFTR (0.47) RAB9ACFTRNPC1MAPTMAPK1
SCHEMBL16338424 0.79 CFTR (0.64) RAB9ACFTRNPC1MAPTLMNA
SCHEMBL19494403 0.78 RAB9A (0.52) RAB9ACFTRNPC1MAPTLMNA
SCHEMBL19494498 0.78 CFTR (0.40) RAB9ACFTRMAPTMAPK1SMN1; SMN2
SCHEMBL16261720 0.77 RAB9A (0.47) RAB9ACFTRNPC1MAPTLMNA
SCHEMBL19494684 0.77 NPC1 (0.46) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL19494323 0.77 CHEK1 (0.37) RAB9ACFTRNPC1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback